In particular, SLC19A3 (solute carrier family 19, member 3 or THTR-2, thiamine transporter-2) which has been found to be down-regulated in gastric and breast cancer [10], [11], [12], could be a potential candidate for this diagnostic purpose. This evidence concerns the gene SLC19A3 and breast cancer.